Adam v. Ledesma-Cadhit

Adam v. Ledesma-Cadhit

The appeal did not raise novel or public interest issues; the respondent, having successfully resisted the appeal, is entitled to costs on a partial indemnity basis; the appropriate award was fixed at $25,000 inclusive of disbursements and applicable taxes, limited to costs associated with time spent by the two...

Source-derived case information.

Citation
2021 ONCA 891
Parties
Appellant: Abudu Ibn Adam; Appellant: May Hyacenth Abudu; Appellant: Ibrahim A.C. Abudu (minor by his litigation guardian Abudu Ibn Adam); Appellant: The Estate of Aminatawalla Napoga Chidinma Abudu (by litigation administrator Abudu Ibn Adam); Respondent: Christine J. Ledesma-Cadhit; Respondent: GlaxoSmithKline Inc.; Respondent: Her Majesty the Queen in Right of Canada; Respondent: Her Majesty the Queen in Right of Ontario
Court
Court of Appeal for Ontario
Jurisdiction
Canada
Judgment Date
13 December 2021
Procedural Posture
Civil / Costs Endorsement on Appeal
Outcome
Appeal resisted by respondent; respondent awarded costs
Legal Topics
Costs, Appeal, Partial Indemnity Costs, Public Interest Exception
Source Language
en
Civil Litigation Costs Appeal Partial Indemnity Costs Public Interest Exception

Source-derived case record

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Legal principles 3 Party arguments 2 Amounts and remedies 3
Sign in to unlock

Parties

Abudu Ibn Adam

Appellant

May Hyacenth Abudu

Appellant

Ibrahim A.C. Abudu (minor by his litigation guardian Abudu Ibn Adam)

Appellant

The Estate of Aminatawalla Napoga Chidinma Abudu (by litigation administrator Abudu Ibn Adam)

Appellant

Christine J. Ledesma-Cadhit

Respondent

GlaxoSmithKline Inc.

Respondent

Her Majesty the Queen in Right of Canada

Respondent

Her Majesty the Queen in Right of Ontario

Respondent

Procedural Posture

Civil / Costs Endorsement on Appeal

  1. 1 Whether the appellants' appeal raised novel or public interest issues warranting no costs
  2. 2 Whether the respondent is entitled to costs for successfully resisting the appeal
  3. 3 What quantum of partial indemnity costs is reasonable in the circumstances

Ratio Decidendi

The appeal did not raise novel or public interest issues; the respondent, having successfully resisted the appeal, is entitled to costs on a partial indemnity basis; the appropriate award was fixed at $25,000 inclusive of disbursements and applicable taxes, limited to costs associated with time spent by the two senior lawyers.

Court Disposition

Appeal resisted by respondent; respondent awarded costs

Orders

  • Respondent GlaxoSmithKline Inc. awarded partial indemnity costs against the appellants fixed at $25,000 inclusive of disbursements and applicable taxes